Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsCan we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?Extracellular Matrix, a Hard Player in AngiogenesisA current view of perlecan in physiology and pathology: A mosaic of functions.Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivoEndostatin and endorepellin: A common route of action for similar angiostatic cancer avengersRecombinant production of proteoglycans and their bioactive domains.Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
P2860
Q21710680-1D6FF8A5-E8D1-42B3-8078-31F5498F9ED2Q24303934-93C710DF-917E-47A6-A0A9-ED49A3866E26Q24312922-758678B8-E3D3-45AC-ADEC-D8077F038A8DQ27021503-068BB3D8-6C48-4E71-ADEF-2BC4901E36DAQ28072886-B4A70620-F2C9-4BF1-AA40-2C03EA6C20DCQ30392738-051BD23A-60EF-43D5-BC13-6102A54470D5Q34411156-EC6C862B-2118-46CA-8FF7-148964BEC10FQ35744566-4BE544C1-2B3A-447C-9D4C-0BBC868A5412Q36578668-E00C0459-287F-433C-8B1A-82B392A5D257Q38082553-FAAE1FE3-DF1D-42D4-9FE6-0514AA72AB58Q38747421-B60E4E13-08D0-4F3E-B671-AD75BAAB6141Q39012517-4F204C00-9404-4734-B406-19D522B1DFEA
P2860
Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@ast
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@en
type
label
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@ast
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@en
prefLabel
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@ast
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@en
P2093
P2860
P356
P1433
P1476
Soluble perlecan domain I enha ...... bone marrow endothelial cells.
@en
P2093
Arivalagan Muthusamy
Carlton R Cooper
Ronald R Gomes
P2860
P2888
P356
10.1186/1471-2091-11-43
P577
2010-11-03T00:00:00Z
P5875
P6179
1052724523